Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial

Overview of attention for article published in Nature Communications, October 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 16 X users

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 16 X posts from 16 X users, with an upper bound of 346,069 followers.

Featured today by @MSKLibrary: Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuva... https://t.co/QSSZpP5Ehd @motzermd @MichaelStaehler @Daniel_J_George

“overlap in key elements captured in these gene expression signatures: * tumor stroma microenvironment * regulatory T cells * myeloid cells suggests likely prognostic & predictive of anti-angiogenic effect in adjuvant setting” #renalCellCarcinoma #ST…

#Molecular characterization of #renal #cell #carcinoma tumors from a phase III anti-angiogenic adjuvant #therapy trial. For more info:https://t.co/K3IxSIBcgn

Recent article in @NatureComms highlights significance of immune response and #TumorEnvironment in identifying effective adjuvant therapy in renal cell carcinoma. Learn more about S-TRAC trial, which utilized Personalis’ comprehensive #genomic solutions: …

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 12 additional X posts.